Skip Navigation

The Bloomberg~Kimmel Institute for Cancer Immunotherapy

Answering the Call to Find a Cure
Our Vision for Immunotherapy
By 2026, cancer deaths will have been reduced by 50%
Our Impact
BKI's innovative cancer treatments have added 300,000 years to patients' lives.
Cutting-Edge Research
15 different cancers can be treated by immunotherapy drugs pioneered at BKI.
""
Research &
Clinical Trials
Our researchers and doctors are using cutting-edge immune-based treatments to find new ways to fight cancer and save lives.
Discover Our Research
Is immunotherapy right for you?
""
What is Cancer Immunotherapy?
We pioneered the leading therapies saving lives today, and we are working on the most promising therapies of tomorrow. Get answers to your questions.
Immunotherapy Explained
image of BKI immunotherapy patient story participants
Our Patients, Our Doctors and Nurses: A Partnership
Brenda's Story
Brenda has been battling triple-negative breast cancer since 1986. Despite radiation, chemotherapy and treatment with an experimental cancer vaccine, her breast cancer continued to return and spread. After joining Dr. Leisha Emens' anti- PD-L1 trial in 2015, her cancer went into remission and remains in remission today.
More Stories
image of the Bloomberg-Kimmel Institute for Cancer Immunotherapy building
About the Institute
Founded in 2016 with a series of philanthropic investments totaling $125 million, the Bloomberg~Kimmel Institute for Cancer Immunotherapy is a groundbreaking collaboration between clinical and scientific specialties, supporting cancer immunotherapy research across many cancer types.
Learn About the Institute
back to top button